全文获取类型
收费全文 | 123991篇 |
免费 | 9634篇 |
国内免费 | 3542篇 |
专业分类
耳鼻咽喉 | 982篇 |
儿科学 | 2327篇 |
妇产科学 | 1778篇 |
基础医学 | 6937篇 |
口腔科学 | 2863篇 |
临床医学 | 14981篇 |
内科学 | 18570篇 |
皮肤病学 | 2299篇 |
神经病学 | 6405篇 |
特种医学 | 4022篇 |
外国民族医学 | 39篇 |
外科学 | 12234篇 |
综合类 | 18176篇 |
现状与发展 | 23篇 |
一般理论 | 2篇 |
预防医学 | 5122篇 |
眼科学 | 2033篇 |
药学 | 10046篇 |
73篇 | |
中国医学 | 10992篇 |
肿瘤学 | 17263篇 |
出版年
2024年 | 196篇 |
2023年 | 2140篇 |
2022年 | 3350篇 |
2021年 | 5468篇 |
2020年 | 5126篇 |
2019年 | 4595篇 |
2018年 | 4354篇 |
2017年 | 4842篇 |
2016年 | 5146篇 |
2015年 | 4907篇 |
2014年 | 8923篇 |
2013年 | 11326篇 |
2012年 | 7306篇 |
2011年 | 7792篇 |
2010年 | 6438篇 |
2009年 | 5912篇 |
2008年 | 5786篇 |
2007年 | 6224篇 |
2006年 | 5569篇 |
2005年 | 4944篇 |
2004年 | 4014篇 |
2003年 | 3634篇 |
2002年 | 2979篇 |
2001年 | 2638篇 |
2000年 | 2182篇 |
1999年 | 1714篇 |
1998年 | 1424篇 |
1997年 | 1197篇 |
1996年 | 996篇 |
1995年 | 890篇 |
1994年 | 701篇 |
1993年 | 544篇 |
1992年 | 482篇 |
1991年 | 441篇 |
1990年 | 377篇 |
1989年 | 330篇 |
1988年 | 320篇 |
1987年 | 276篇 |
1986年 | 216篇 |
1985年 | 254篇 |
1984年 | 223篇 |
1983年 | 165篇 |
1982年 | 165篇 |
1981年 | 164篇 |
1980年 | 130篇 |
1979年 | 121篇 |
1978年 | 65篇 |
1977年 | 42篇 |
1976年 | 50篇 |
1975年 | 32篇 |
排序方式: 共有10000条查询结果,搜索用时 296 毫秒
991.
〔摘 要〕 目的:探究基于数据挖掘的刺络放血疗法治疗外感发热的选穴规律。 方法:2019 年 7 月至 2019 年 12 月采
用 Excel 2019 建立刺络放血数据仓库模型,随后下载、筛选已建数据库中刺络放血疗法治疗外感发热的文献资料,以及所
需信息的录入,借助建立的刺络放血数据库平台,对其进行数据挖掘。 结果:纳入刺络放血疗法治疗外感发热的文献共计
63 篇,其中刺络放血针具三棱针使用频次最高,刺络放血刺法使用频次最高的为点刺;刺络放血治疗未配合拔罐的研究
占比 80 %;采用刺络放血配合疗法的有 46 项,占比 73 %,其中以拔罐使用频次最高。 结论:刺络放血疗法治疗外感发热
以三棱针点刺治疗为主,且部分研究常配合其他疗法以明显提升治疗效果,但配合拔罐治疗临床应用较少。 相似文献
992.
目的分析雌孕激素序贯用药治疗流产术后宫腔残留患者的临床价值。方法选取2017年1月至2019年12月我站收治的人工流产患者60例,按治疗方式不同分为对照组(28例)和观察组(32例)。对照组采用刮宫治疗,观察组于人工流产术后第7 d行B超检查,观察宫腔残留情况后采用药物治疗。比较两组的临床疗效、并发症。结果两组的总有效率比较无统计学差异(P>0.05)。观察组的腹痛发生率低于对照组,出血时间短于对照组(P <0.05)。结论雌孕激素序贯用药治疗能够有效清除宫腔残留,缩短出血时间,减轻腹痛,有利于重新建立正常的月经周期,促进子宫功能修复,避免再次刮宫对子宫内膜的损伤及手术对患者造成的不良身心应激,具有较高的临床推广价值。 相似文献
993.
目的探讨共情护理对女性抑郁症脑电生物反馈治疗患者治疗依从性及生活功能的影响。方法选择2018年1月至2019年6月于我院行脑电生物反馈治疗的女性抑郁症患者98例,根据护理方法不同分为对照组(49例,常规护理)与观察组(49例,共情护理)。比较两组的治疗依从性和生活功能。结果干预后,观察组用药、自我观察、临床护理依从性均高于对照组(P <0.05)。干预后,观察组的躯体功能、心理功能、社会功能、物质生活评分高于对照组(P <0.05)。结论共情护理可提高女性抑郁症脑电生物反馈治疗患者的治疗依从性和生活功能,促进患者恢复。 相似文献
994.
目的探讨尼莫地平联合亚低温疗法治疗蛛网膜下腔出血(SAH)后脑血管痉挛的疗效。方法 93例SAH后脑血管痉挛患者随机分为两组。在常规治疗基础上,对照组采用亚低温疗法治疗,观察组采用尼莫地平联合亚低温疗法治疗。比较两组的治疗效果。结果观察组的总有效率为95.74%,高于对照组的80.43%(P <0.05)。治疗后,观察组的IL-6、 TNF-α、 hs-CRP水平均低于对照组,动脉平均血流速度高于对照组(P <0.05)。结论尼莫地平联合亚低温疗法治疗SAH后脑血管痉挛的效果显著,可有效抑制机体炎性反应,提升动脉平均血流速度。 相似文献
995.
The available drug therapy for post-ischemic neurodegeneration of the brain is symptomatic. This review provides an evaluation of possible dietary therapy for post-ischemic neurodegeneration with myricetin. The purpose of this review was to provide a comprehensive overview of what scientists have done regarding the benefits of myricetin in post-ischemic neurodegeneration. The data in this article contribute to a better understanding of the potential benefits of myricetin in the treatment of post-ischemic brain neurodegeneration, and inform physicians, scientists and patients, as well as their caregivers, about treatment options. Due to the pleiotropic properties of myricetin, including anti-amyloid, anti-phosphorylation of tau protein, anti-inflammatory, anti-oxidant and autophagous, as well as increasing acetylcholine, myricetin is a promising candidate for treatment after ischemia brain neurodegeneration with full-blown dementia. In this way, it may gain interest as a potential substance for the prophylaxis of the development of post-ischemic brain neurodegeneration. It is a safe substance, commercially available, inexpensive and registered as a pro-health product in the US and Europe. Taken together, the evidence available in the review on the therapeutic potential of myricetin provides helpful insight into the potential clinical utility of myricetin in treating neurodegenerative disorders with full-blown dementia. Therefore, myricetin may be a promising complementary agent in the future against the development of post-ischemic brain neurodegeneration. Indeed, there is a scientific rationale for the use of myricetin in the prevention and treatment of brain neurodegeneration caused by ischemia. 相似文献
996.
Dorota Skrzypczak Alicja Ewa Ratajczak Aleksandra Szymczak-Tomczak Agnieszka Dobrowolska Piotr Eder Iwona Krela-Ka
mierczak 《Nutrients》2021,13(2)
Sarcopenia is a disorder characterized by a loss of muscle mass which leads to the reduction of muscle strength and a decrease in the quality and quantity of muscle. It was previously thought that sarcopenia was specific to ageing. However, sarcopenia may affect patients suffering from chronic diseases throughout their entire lives. A decreased mass of muscle and bone is common among patients with inflammatory bowel disease (IBD). Since sarcopenia and osteoporosis are closely linked, they should be diagnosed as mutual consequences of IBD. Additionally, multidirectional treatment of sarcopenia and osteoporosis including nutrition, physical activity, and pharmacotherapy should include both disorders, referred to as osteosarcopenia. 相似文献
997.
The prevalence of obesity continues to grow rapidly worldwide, posing many public health challenges of the 21st century. Obese subjects are at major risk for serious diet-related noncommunicable diseases, including type 2 diabetes mellitus, cardiovascular disease, and non-alcoholic fatty liver disease. Understanding the mechanisms underlying obesity pathogenesis is needed for the development of effective treatment strategies. Dysregulation of incretin secretion and actions has been observed in obesity and related metabolic disorders; therefore, incretin-based therapies have been developed to provide new therapeutic options. Incretin mimetics present glucose-lowering properties, together with a reduction of appetite and food intake, resulting in weight loss. In this review, we describe the physiology of two known incretins—glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), and their role in obesity and related cardiometabolic disorders. We also focus on the available and incoming incretin-based medications that can be used in the treatment of the above-mentioned conditions. 相似文献
998.
ObjectivesThe aim of this study was to investigate the impact of mixed cognitive intervention training using spaced retrieval training, and errorless learning in participants with early onset dementia. This was based on reality orientation therapy for cognitive function, depression, and occupational performance of patients.MethodsTwo early onset vascular dementia patients (> 65 years) with mild or moderate impairment were enrolled in a pre-test - post-test single-subject research design study. Prior to the study, the caregivers were interviewed about meaningful times, people, places, and areas of interest for the participant. A list of individual training words were selected based upon this information, and the participant was instructed to recall them after a 45-second, 90-second, 6-minute, and 12-minute delay. Baseline (3 sessions), intervention (20 sessions), and a second baseline period (3 sessions) were conducted. Activities of daily living were measured, and cognition was measured using the Consortium to Establish a Registry of Alzheimer’s Disease Korean version, whilst depression was measured using the Korean Form Geriatric Depression Scale, and task performance and satisfaction measured by the Canadian Occupational Performance Measure.ResultsAfter intervention, both participants showed improvements in activities of daily living (ADL), word list memory/recognition, trail making A, occupational performance, and satisfaction improvement, which was clinically significant in 1 participant who also had a reduced score in the scale of depression classifying him as not depressed.ConclusionSpaced retrieval training and errorless learning based on reality orientation therapy is an effective intervention in patients with early onset dementia and mild or moderate impairment. 相似文献
999.
Martin Gnoni Renato Beas Anupama Raghuram Celeste D az-Pardav Adrian Riva-Moscoso Fortunato S Pr ncipe-Meneses Ra l V squez-Garagatti 《World Journal of Experimental Medicine》2021,11(5):66-78
Cardiovascular disease (CVD) has become one of the commonest causes of comor bidity and mortality among People living with human immunodeficiency virus (HIV) (PLWH) on antiretroviral therapy (ART). Nearly 50% of PLWH are likely to have an increased risk of developing CVD, including coronary heart disease, cerebrovascular disease, peripheral artery disease and aortic atherosclerosis. Aside from the common risk factors, HIV infection itself and side effects of antiretroviral therapy contribute to the pathophysiology of this entity. Potential non-pharmacological therapies are currently being tested worldwide for this purpose, including eating patterns such as Intermittent fasting (IF). IF is a widespread practice gaining high level of interest in the scientific community due to its potential benefits such as improvement in serum lipids and lipoproteins, blood pressure (BP), platelet-derived growth factor AB, systemic inflammation, and carotid artery intima-media thickness among others cardiovascular benefits. This review will focus on exploring the potential role of intermittent fasting as a non-pharmacological and cost-effective strategy in decreasing the burden of cardiovascular diseases among HIV patients on ART due to its intrinsic properties improving the main cardiovascular risk factors and modulating inflammatory pathways related to endothelial dysfunction, lipid peroxidation and aging. Intermittent fasting regimens need to be tested in clinical trials as an important, cost-effective, and revolutionary coadjutant of ART in the fight against the increased prevalence of cardiovascular disease in PLWH. 相似文献
1000.